http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004086963-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4747 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 2001-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec54830d942539e0ff39219632fbc82b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eac8f7cfce6bc2928b8ca88587a5a61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14cc9cc5300c4cdde3fe43f04090e947 |
| publicationDate | 2004-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2004086963-A1 |
| titleOfInvention | Tumor and senescence marker |
| abstract | The present invention relates to cell-regulatory proteins and to nucleotide sequences encoding said proteins wherein the proteins have been found to be potential tumor and/or senescense markers useful for medical diagnostics and additionally having therapeutical potential as well as antiapoptotic properties useful for improving cell viability in cell culture technology. The invention further relates to antibodies directed against the cell-regulatory proteins and to their use in medical diagnostics and therapy. The invention further relates to methods for the manufacture and application of the cell-regulatory proteins and of the corresponding nucleotide sequences. |
| priorityDate | 2000-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 666.